Biology Methods and Protocols · 13 Nov 2026
Large-scale data extraction from clinical notes reveals the lean-mass fraction of weight-loss in patients treated with GLP-1 medicines
Karthik Murugadoss, A J Venkatakrishnan, Venky Soundararajanh-index 19
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Body-composition measurements are often recorded in the free text of electronic health record (EHR) notes, limiting large-scale assessment of the composition of weight change. We evaluated a large language model (LLM)-based pipeline for extracting and harmonizing these measurements and characterizing the lean-mass proportion of weight change. Among 670,422 adults initiating semaglutide or tirzepatide, the pipeline yielded 158,573 harmonized lean body mass (LBM) measurements for 29,154 patients; 7,965 had baseline and follow-up measurements. Manual review of a sample of 53 notes found correct values and units in all 32 notes with extracted LBM values and correct dates in 93.8%, with no missed values in 21 screened negatives. Repeat extraction showed 95%–97% agreement for values, units, and dates. Across a wider clinical-note corpus, analyses of 1,907 weight-loss-associated medications, procedures, and conditions distinguished relatively lean-sparing loss with bariatric surgery (lean-mass proportion, 0.24), semaglutide (0.27), and tirzepatide (0.26) from lean-depleting loss with catabolic illness (0.70–0.74). Analyses of 427 weight-gain-associated entities distinguished fat-predominant from lean- or fluid-predominant gain. Matched comparisons generally placed incretin therapies between lifestyle counseling and bariatric surgery in weight and LBM loss. Comparing tirzepatide with semaglutide, the covariate-adjusted 12-month difference in LBM change was −1.9 percentage points (95% CI, −3.6 to − 0.3), attenuating to − 0.1 (95% CI, −1.6 to 1.4) after adjustment for concurrent weight change. Among 465 matched pairs, the 12-month lean-mass proportion of weight lost did not differ significantly (0.24 vs 0.22; difference, 0.02; 95% CI, −0.04 to 0.09). These observational findings support scalable assessment of body composition from routine EHR notes and suggest that tirzepatide’s greater LBM loss accompanies greater weight loss.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Venky Soundararajan has the highest h-index among the authors (19).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.